{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:48:26Z","timestamp":1790819306921,"version":"4.1.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201606100058"],"award-info":[{"award-number":["201606100058"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","award":["ES\/L007517\/1"],"award-info":[{"award-number":["ES\/L007517\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Health Policy Research Programme","award":["109\/0001"],"award-info":[{"award-number":["109\/0001"]}]},{"name":"Child Health Research CIO (CHR CIO) Trust"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0212212","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T18:57:05Z","timestamp":1550602625000},"page":"e0212212","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"14","author":[{"given":"Heng","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-2922","authenticated-orcid":true,"given":"Linda","family":"Wijlaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/jac\/dkq307","article-title":"Oral antibiotic prescribing during pregnancy in primary care: UK population-based study","volume":"65","author":"I Petersen","year":"2010","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","article-title":"Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study","volume":"163","author":"KS Crider","year":"2009","journal-title":"Archives of pediatrics & adolescent medicine"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2007-994053","article-title":"A prospective controlled multicentre study of clarithromycin in pregnancy","volume":"15","author":"A Einarson","year":"1998","journal-title":"Am J Perinatol"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.reprotox.2005.01.010","article-title":"Is erythromycin therapy teratogenic in humans?","volume":"20","author":"BA Kallen","year":"2005","journal-title":"Reproductive toxicology (Elmsford, NY)"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"e0122034","DOI":"10.1371\/journal.pone.0122034","article-title":"Association between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the health improvement network","volume":"10","author":"WH Meeraus","year":"2015","journal-title":"PLoS One"},{"issue":"9646","key":"ref6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(08)61203-9","article-title":"Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial","volume":"372","author":"S Kenyon","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"e53327","DOI":"10.1371\/journal.pone.0053327","article-title":"Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study","volume":"8","author":"JT Andersen","year":"2013","journal-title":"PLoS One"},{"issue":"17","key":"ref8","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1503\/cmaj.161020","article-title":"Use of antibiotics during pregnancy and risk of spontaneous abortion","volume":"189","author":"FT Muanda","year":"2017","journal-title":"CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00228-013-1624-3","article-title":"Fetal safety of erythromycin. An update of Swedish data","volume":"70","author":"B Kallen","year":"2014","journal-title":"European journal of clinical pharmacology"},{"key":"ref10","first-page":"25","article-title":"Teratogenic risk of macrolides during the first trimester of pregnancy: A study with two complementary approaches within the EFEMERIS database","volume":"31","author":"T Le Nguyen","year":"2017","journal-title":"Fundamental and Clinical Pharmacology"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2012.12.023","article-title":"Safety of macrolides during pregnancy","volume":"208","author":"KJ Lin","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2393-6-18","article-title":"Pregnancy outcome following gestational exposure to azithromycin","volume":"6","author":"M Sarkar","year":"2006","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2125.2012.04286.x","article-title":"Pregnancy outcome after gestational exposure to erythromycin\u2014a population-based register study from Norway","volume":"74","author":"M Romoren","year":"2012","journal-title":"British journal of clinical pharmacology"},{"key":"ref14","unstructured":"Guardian T. Antibiotic used in pregnancy linked to risk of epilepsy and cerebral palsy 2015 [cited 2017]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.theguardian.com\/science\/2015\/mar\/25\/antibiotic-used-in-pregnancy-linked-to-risk-of-epilepsy-and-cerebral-palsy\" xlink:type=\"simple\">https:\/\/www.theguardian.com\/science\/2015\/mar\/25\/antibiotic-used-in-pregnancy-linked-to-risk-of-epilepsy-and-cerebral-palsy<\/ext-link>."},{"key":"ref15","unstructured":"FDA U. FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms 2013 [cited 2017 26.06.2017]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm341822.htm\" xlink:type=\"simple\">https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm341822.htm<\/ext-link>."},{"key":"ref16","unstructured":"FDA U. FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease. 2018."},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40264-017-0533-2","article-title":"Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis","volume":"40","author":"AYS Wong","year":"2017","journal-title":"Drug safety"},{"issue":"20","key":"ref18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","article-title":"The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk","volume":"66","author":"YJ Cheng","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref19","unstructured":"Winkel P, Hilden J, Hansen JF, Kastrup J, Kolmos HJ, Kjoller E, et al. Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial. (1874\u20131754 (Electronic))."},{"key":"ref20","unstructured":"Britain) JFCG. British National Formulary. Pharmaceutical Press; 2016. p. 307."},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/14740338.2014.939580","article-title":"Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity","volume":"13","author":"HF Lamont","year":"2014","journal-title":"Expert opinion on drug safety"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1179\/joc.2005.17.2.123","article-title":"Antibiotic therapy in pregnancy and lactation","volume":"17","author":"A Reali","year":"2005","journal-title":"Journal of Chemotherapy"},{"key":"ref23","article-title":"Drugs in Pregnancy and Lactation","author":"GG Briggs","year":"2017"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration&apos;s tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"JA Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"MJS, A.J. Sweeting","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-3016.2008.00978.x","article-title":"Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations","volume":"23","author":"WO Cooper","year":"2009","journal-title":"Paediatric and perinatal epidemiology"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/0002-9378(91)90506-M","article-title":"A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group","volume":"164","author":"DA Eschenbach","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"9646","key":"ref29","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(08)61202-7","article-title":"Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial","volume":"372","author":"S Kenyon","year":"2008","journal-title":"Lancet"},{"issue":"9261","key":"ref30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(00)04234-3","article-title":"Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group","volume":"357","author":"SL Kenyon","year":"2001","journal-title":"Lancet"},{"issue":"9261","key":"ref31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(00)04233-1","article-title":"Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group","volume":"357","author":"SL Kenyon","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.placenta.2013.01.016","article-title":"The efficacy of cefazolin plus macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and placental inflammation for women with preterm premature rupture of membranes","volume":"34","author":"HM Kwak","year":"2013","journal-title":"Placenta"},{"issue":"1","key":"ref33","first-page":"10","article-title":"Double-Blind Placebo-Controlled Treatment Trial of Chlamydia trachomatis Endocervical Infections in Pregnant Women","volume":"5","author":"DH Martin","year":"1997","journal-title":"Infectious diseases in obstetrics and gynecology"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0002-9378(91)90299-7","article-title":"Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin","volume":"165","author":"JA McGregor","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9378(92)91336-9","article-title":"Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients","volume":"166","author":"BM Mercer","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"ref36","article-title":"Use of antibiotics during pregnancy and the risk of major congenital malformations: A population based cohort study","author":"FT Muanda","year":"2017","journal-title":"British journal of clinical pharmacology"},{"issue":"13","key":"ref37","article-title":"Adjunctive Azithromycin Prophylaxis for Cesarean Delivery","volume":"375","author":"AT Tita","year":"2016","journal-title":"New England journal of medicine"},{"issue":"4","key":"ref38","first-page":"293","article-title":"Clinic intervention study on urogenital mycoplasma infection of pregnant women","volume":"22","author":"Y Ye","year":"2001","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"g1908","DOI":"10.1136\/bmj.g1908","article-title":"Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study","volume":"348","author":"M Lund","year":"2014","journal-title":"Bmj"},{"issue":"7251","key":"ref40","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.320.7251.1708","article-title":"Maternal age and fetal loss: population based register linkage study","volume":"320","author":"Anne-Marie Nybo","year":"2000","journal-title":"British medical journal"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","article-title":"How common are the &quot;common&quot; neurologic disorders?","volume":"68","author":"D Hirtz","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/bdra.20735","article-title":"Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004\u20132006","volume":"88","author":"SE Parker","year":"2010","journal-title":"Birth defects research Part A, Clinical and molecular teratology"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/sti.2002.004077","article-title":"Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries","volume":"81","author":"S Mullick","year":"2005","journal-title":"Sexually Transmitted Infections"},{"key":"ref44","unstructured":"The National Institute for Health and Care Excellence (NICE). CLARITHROMYCIN 2018. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/bnf.nice.org.uk\/drug\/clarithromycin.html#pregnancy\" xlink:type=\"simple\">https:\/\/bnf.nice.org.uk\/drug\/clarithromycin.html#pregnancy<\/ext-link>."},{"key":"ref45","unstructured":"Health Canada. PRODUCT MONOGRAPH: rRAN\u2122-CLARITHROMYCIN 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/health-products.canada.ca\/dpd-bdpp\/info.do?lang=en&code=87557\" xlink:type=\"simple\">https:\/\/health-products.canada.ca\/dpd-bdpp\/info.do?lang=en&amp;code=87557<\/ext-link>."},{"key":"ref46","unstructured":"Danish Medicines Agency. Clarithromycin 2018. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/produktresume.dk\/AppBuilder\/search?button=S%C3%B8g&id=&page=0&q=clarithromycin&type=&utf8=%E2%9C%93\" xlink:type=\"simple\">http:\/\/produktresume.dk\/AppBuilder\/search?button=S%C3%B8g&amp;id=&amp;page=0&amp;q=clarithromycin&amp;type=&amp;utf8=%E2%9C%93<\/ext-link>."},{"key":"ref47","unstructured":"The United States Food and Drug Administration. BIAXIN\u00ae Filmtab\u00ae 2012. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/050662s044s050,50698s026s030,050775s015s019lbl.pdf\" xlink:type=\"simple\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/050662s044s050,50698s026s030,050775s015s019lbl.pdf<\/ext-link>."},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1155\/2001\/657353","article-title":"Macrolides: A Canadian Infectious Disease Society position paper","volume":"12","author":"S McKenna","year":"2001","journal-title":"Can J Infect Dis"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1067\/mob.2003.171","article-title":"Placental passage of clarithromycin surpasses other macrolide antibiotics","volume":"188","author":"A Witt","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cvr\/cvs296","article-title":"Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism","volume":"97","author":"C Danielsson","year":"2013","journal-title":"Cardiovascular research"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/bdrc.20102","article-title":"The effect of hypoxia in development","volume":"81","author":"WS Webster","year":"2007","journal-title":"Birth Defects Res C Embryo Today"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"b3569","DOI":"10.1136\/bmj.b3569","article-title":"Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study","volume":"339","author":"LH Pedersen","year":"2009","journal-title":"BMJ"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdra.20627","article-title":"First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies","volume":"88","author":"KE Wurst","year":"2010","journal-title":"Birth defects research Part A, Clinical and molecular teratology"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1128\/AAC.01691-12","article-title":"Fetal safety of macrolides","volume":"57","author":"A Bahat Dinur","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref55","unstructured":"Public Health England. Management and treatment of common infections: Antibiotic guidance for primary care: For consultation and local adaptation. In: Public Health England, editor. 2017."},{"key":"ref56","unstructured":"National Clinical Programme for Obstetrics and Gynaecology. Medication Guidelines For Obstetrics and Gynaecology. 2017."},{"key":"ref57","unstructured":"UK Teratology Information Service. Use of azithromycin in pregnancy 2012. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.medicinesinpregnancy.org\/bumps\/monographs\/USE-OF-AZITHROMYCIN-IN-PREGNANCY\/\" xlink:type=\"simple\">http:\/\/www.medicinesinpregnancy.org\/bumps\/monographs\/USE-OF-AZITHROMYCIN-IN-PREGNANCY\/<\/ext-link>."},{"key":"ref58","unstructured":"UK Teratology Information Service. Use of clarithromycin in pregnancy 2012. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.medicinesinpregnancy.org\/bumps\/monographs\/USE-OF-CLARITHROMYCIN-IN-PREGNANCY\/\" xlink:type=\"simple\">http:\/\/www.medicinesinpregnancy.org\/bumps\/monographs\/USE-OF-CLARITHROMYCIN-IN-PREGNANCY\/<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0212212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:56:28Z","timestamp":1588996588000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0212212"}},"subtitle":[],"editor":[{"given":"Lorenza","family":"Scotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0212212","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]}}}